Can ULEZ really reverse permanent damage to children's lungs?

ULEZ and children's lung health recovery is a documented biological phenomenon where developing lungs gain measurable capacity as urban nitrogen dioxide levels decline. The CHILL study, tracking 3,400 children in London and Luton between 2018 and 2023, found that London’s emission zone allowed children to gain an extra 10 ml of lung capacity annually.

When nitrogen dioxide levels fall, developing lungs can physically heal and catch up to their peers, reversing damage previously considered permanent. Between 2018 and 2023, 3,400 children in London and Luton participated in a massive natural experiment that changed our understanding of human biology. The results, published in The Lancet Public Health in August 2026, have upended decades of respiratory science.

The CHILL study shows that lungs can actually heal when the air clears. In London, where the Ultra Low Emission Zone (ULEZ) was introduced, children gained an extra 10 ml of lung capacity for every year that nitrogen dioxide levels fell. Their lung growth accelerated, allowing them to catch up with peers who lived in less polluted areas.

Scientists were surprised by these findings. The consensus was that pollution-induced stunting was irreversible. We treated it as a permanent handicap that increased the lifelong risk of heart disease and metabolic issues.

The data proves that this damage is not a fixed fate. Across 84 primary schools, the proportion of London children with clinically impaired lung function dropped from 14% to 9% during the study. In the control city of Luton, which did not implement a similar zone, the improvement was much flatter, moving only from 9% to 7%.

This is the first time we have seen "catch-up growth" in pediatric respiratory health at this scale. Despair is just procrastination with better PR, and these numbers provide a clear map for what happens when we stop stalling. It is finally possible to talk about reversing the damage already done.

The Engineering of a Study: London vs. Luton

The CHILL study is a masterclass in longitudinal research that favors measurement over estimates. Starting in 2018, before the Ultra Low Emission Zone (ULEZ) launched, researchers began tracking 3,400 children. These students, aged six to nine, were recruited from 84 primary schools across London and Luton.

The data collection spanned five years, concluding in 2023. To determine if a policy actually works, you need a baseline and a control. Luton served as that vital scientific anchor because its demographic and traffic profiles mirrored London’s, but it did not implement a similar low-emission charging zone.

This was a massive collaborative effort led by Queen Mary University of London. The research team included specialists from Imperial College London, Oxford, Cambridge, Bedfordshire, and Edinburgh. The National Institute for Health and Care Research (NIHR) funded the work, ensuring high-precision monitoring over half a decade.

A longitudinal approach is the only way to move past guesswork. By following the same cohort, researchers could see how individual lung capacity changed as nitrogen dioxide levels fell. This methodology provided the necessary rigor to move the conversation from political debate to clinical evidence.

It is easy to claim a policy is green. It is much harder to prove that it physically changes a child’s body. This study remains the most detailed look at how urban air policy translates into biological outcomes.

The Numbers: Quantifying ULEZ and Children's Lung Health Recovery

When the study began in 2018, the baseline was biologically grim. London children started with an average forced expiratory volume (FEV1) 38 ml lower than their peers in Luton. This volume was a measurable physical penalty for simply living in a major capital city.

The intervention changed the data trajectory through a clear mechanical cause. During the five-year period, nitrogen dioxide (NO2) levels in London fell twice as fast and twice as much as in Luton. This was the direct result of a policy that priced polluting engines out of the urban center.

Despair is just procrastination with better PR, and these numbers provide a clear map for what happens when we stop stalling.

The most striking figure for any parent is the 10 ml annual gain. For every year of falling NO2 exposure, London children gained an additional 10 ml of lung capacity compared to the control group. This biological lever proves that lungs are responsive organs rather than static maps of permanent damage.

We must also look at clinical impairment, which identifies children at risk of lifelong chronic conditions. In London, the proportion of children with impaired lung function dropped significantly from 14% to 9%. The gap between these outcomes is the measure of the policy's real-world impact on future healthcare burdens.

These numbers show that clean air policy is a measurable return on investment in human hardware. The catch is that both cities still sit above WHO air quality guidelines despite these improvements. The work remains unfinished until those health targets are met for every child.

Naming the Catch: Compliance, Costs, and Invisible Dust

In a small workshop in East London, a mechanic wipes grease from the engine of a 2000-model hatchback. To the owner, this car is a reliable tool for a daily commute. To the ULEZ system, it is a data ghost because vehicles built before 2001 often lack official emissions figures.

The price of clean air has been measured in daily charges and forced vehicle upgrades. For families on a tight budget, the daily entry fee is a significant financial wall. It represents a direct, uncomfortable trade-off between pediatric respiratory health and individual economic mobility.

Even with the gains in lung capacity, the air is not pure in any absolute sense. Monitoring stations confirm that both London and Luton still exceed World Health Organization (WHO) guideline levels. We have moved the dial from "dangerous" to "better," but we have not yet reached "safe" by global medical standards.

There is also the matter of what the tailpipe does not capture, specifically the invisible dust of urban transit. Tire wear and brake shavings create a constant trail of particles that no exhaust filter can stop. Researchers still face questions about how these non-exhaust PM2.5 particles specifically affect pediatric lung development.

We have identified a lever that measurably reverses biological damage, but we must remain honest about who pays and what remains. The mission for urban health has simply moved from a desperate sprint to a long, methodical climb. Biological recovery is underway, but the environmental chemistry is still evolving.

The Economic and Health Dividend: A Map for Other Cities

Most urban environmental policies act as symbolic gestures. We paint a green bike lane or plant twenty saplings and call it progress, even if the needle barely moves. The ULEZ data represents a shift from these measures to a measurable policy lever.

It moves the narrative from simple mitigation to actual biological reversal. Stunting in early development is directly linked to an increased risk of COPD and cardiovascular disease in adulthood. A 10 ml annual gain in lung capacity is a buffer against a future of chronic medication and respiratory failure.

This recovery creates a massive economic health dividend. We can now project long-term savings for health systems like the NHS based on these improvements. Treating a child today with clean air is exponentially cheaper than managing systemic illness in forty years.

The London evidence replaces the vague "costs" of regulation with the concrete "returns" of a healthier workforce. For cities like Tallinn, the lesson is clear. We often treat traffic restrictions as a trade-off between convenience and climate targets, but we should view them as public health infrastructure.

When we choose to implement clean air zones, we are not just meeting a CO2 quota. We are investing in the primary respiratory health of the next generation. It is a choice between the theater of greening and the engineering of health.

The Honest Scorecard: What Actually Works

The CHILL study provides a rare, verifiable win for urban policy. In London, the proportion of children with clinically impaired lung function dropped by 5% after ULEZ was introduced. Moving the needle across a population of 3,400 children is a measurable success rather than a symbolic gesture.

However, an honest scorecard requires acknowledging the gaps in our current knowledge. We know these children’s lungs "caught up" by age 11 to 14, but we do not know if they will face sensitivity later in life. The data also leaves a question mark over whether children from the most deprived families saw the same rate of recovery.

We must treat air quality as a medical priority rather than a simple traffic tax. For parents, this evidence justifies demanding low-emission zones near primary schools. The evidence for ULEZ and children's lung health recovery shows that damage is not a permanent debt we must carry.